| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Wentworth Kory James is a Chief Financial Officer at TRDA. Recent filings cover 0 purchases and 37 sales. Those positions are worth an estimated $838K at current prices.
Our model assigns Wentworth Kory James a middling insider score of 61/100, based on 28 past trades. Over a 12-month horizon, 48.1% of those trades were profitable, with an average 12-month return of +6.4%.
Wentworth Kory James's largest disclosed position is in TRDA as Chief Financial Officer, worth about $838K. The recent filings there lean toward selling, a net 128,816 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 12,500 | $15.59 | $194,845.26 | -20.1% | -19.8% | +6.3% | |
| Sep 6, 2023 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 950 | $13.48 | $12,806.17 | -1.9% | +1.2% | +10.9% | |
| Jul 11, 2023 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 10,000 | $17.99 | $179,862.18 | -21.4% | -20.9% | -12.6% | |
| Jun 21, 2023 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 17,500 | $15.01 | $262,648.25 | -38.5% | -5.1% | -4.7% | |
| Mar 2, 2023 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sell | 1,747 | $10.53 | $18,389.01 | -4.0% | +12.9% | +35.3% | |
| Dec 8, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 4,550 | $18.95 | $86,237.97 | -21.6% | -45.6% | -32.2% | |
| Dec 5, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,110 | $18.19 | $56,559.49 | -15.9% | -41.6% | -21.8% | |
| Nov 16, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 200 | $18.10 | $3,620.00 | -1.2% | -25.3% | -11.9% | |
| Aug 25, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 4,669 | $13.78 | $64,361.54 | -29.8% | -2.0% | +7.7% | |
| Aug 23, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 11,655 | $13.08 | $152,432.02 | -44.5% | +9.8% | +25.3% |